M&A Deal Summary

North Castle Partners Acquires NEST New York

On November 7, 2022, private equity firm North Castle Partners acquired consumer products company NEST New York from Eurazeo PME for 200M USD

Acquisition Highlights
  • This is North Castle Partners’ 19th transaction in the Consumer Products sector.
  • This is North Castle Partners’ largest (disclosed) transaction.
  • This is North Castle Partners’ 46th transaction in the United States.
  • This is North Castle Partners’ 10th transaction in New York.

M&A Deal Summary

Date 2022-11-07
Target NEST New York
Sector Consumer Products
Buyer(s) North Castle Partners
Sellers(s) Eurazeo PME
Deal Type Secondary Buyout
Deal Value 200M USD
Advisor(s) Perella Weinberg Partners (Financial)

Target

NEST New York

New York, New York, United States
NEST New York is a designer and manufacturer of luxury home fragrances, personal care products and fine fragrances. Company offers a collection of over 30 home and fine fragrances sold in luxury department stores, specialty retailers and upscale boutiques, as well as on QVC and nestnewyork.com. NEST New York was founded in 2008 and is based in New York City.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

North Castle Partners

Greenwich, Connecticut, United States

Investor


Category Private Equity Firm
Founded 1997
Size Middle-Market
Type Sector Focused
DESCRIPTION

North Castle Partners is a specialist private equity firm that targets investments in consumer-driven product and service businesses. North Castle seeks control investments in companies that benefit from consumers looking to live 'healthier' lives as well as businesses that benefit from the baby boomer population. Specific areas of interest include aesthetics and personal care, consumer health, fitness and recreation, home and leisure, and nutrition. North Castle was formed in 1997 and is based in Greenwich, Connecticut.


DEAL STATS #
Overall 48 of 48
Sector (Consumer Products) 19 of 19
Type (Secondary Buyout) 4 of 4
State (New York) 10 of 10
Country (United States) 46 of 46
Year (2022) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-20 Therabody

Los Angeles, California, United States

Therabody is a wellness technology company with a mission to inspire and enable everybody and the mind to keep moving. The company's products and content are embraced by the medical community, sports and beauty industry leaders, and millions of consumers worldwide. Currently available in more than 60 countries, including at company-owned retail stores and at Reset, a whole-body wellness and recovery center, the product line includes proprietary technologies and leverages biometrics for personalized real-time therapies. Therabody was founded in 2007 and is based in Los Angeles, California.

Buy -

Seller(S) 1

SELLER

Eurazeo PME

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1997
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Eurazeo PME, formerly known as OFI Private Equity Capital. Eurazeo PME invests equity and mezzanine capital in secondary buyout transactions of unlisted French companies. The Firm looks for opportunities valued between €50 and €250 million. Areas of interest include chemicals, financial services, consumer services, retail, manufacturing, distribution, and life science. Eurazeo PME was formed in 1997 and is based in Paris.


DEAL STATS #
Overall 28 of 29
Sector (Consumer Products) 2 of 2
Type (Secondary Buyout) 16 of 16
State (New York) 1 of 1
Country (United States) 3 of 3
Year (2022) 2 of 2
Size (of disclosed) 6 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-08 Imapole

Villeurbanne, France

Imapole is a medical imaging group with 24 machines including four scanners and two MRI machines and handles 170,000 patients per year. The main site is connected to Medipole Lyon-Villeurbanne, hospital with 750 beds and a 24/7 emergency department Imapole is at the forefront of the care offering in its catchment area, which is short of imaging capacity. Imapole was founded in 2018 and is based in Villeurbanne, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-21 NeoXam

Paris, France

NeoXam is a provider of investment accounting, investment management, and data management software solutions. NeoXam's customer base is made of large and medium asset management firms, investment banks, institutional investors, and securities services providers. NeoXam was founded in 2014 and is based in Paris, France.

Buy -